论文部分内容阅读
肿瘤抗原特异细胞毒T细胞(CTL)是特异性免疫靶向治疗的理想免疫细胞,近年来对血液肿瘤抗原诱导特异性CTL的诱导和应用研究有很大的发展。
Tumor antigen-specific cytotoxic T lymphocytes (CTLs) are the ideal immune cells for specific immune targeted therapy. In recent years, there has been a great development in the induction and application of hematological tumor antigen-specific CTLs.